
San Ming R. Hui
Examiner (ID: 1844, Phone: (571)272-0626 , Office: P/1621 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1629, 1617, 1621, 1627, 1628 |
| Total Applications | 2265 |
| Issued Applications | 1024 |
| Pending Applications | 278 |
| Abandoned Applications | 986 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18280892
[patent_doc_number] => 20230096364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/740698
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17740698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/740698 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | May 9, 2022 | Abandoned |
Array
(
[id] => 17805714
[patent_doc_number] => 20220257549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHOD FOR TREATMENT OF PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/736494
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736494
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736494 | Method for treatment of Parkinson's disease | May 3, 2022 | Issued |
Array
(
[id] => 19389332
[patent_doc_number] => 20240279202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/289513
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 124088
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289513
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289513 | COMPOUNDS FOR INHIBITING OR DEGRADING ITK, COMPOSITIONS, COMPRISING THE SAME METHODS OF THEIR MAKING AND METHODS OF THEIR USE | May 2, 2022 | Pending |
Array
(
[id] => 17981134
[patent_doc_number] => 20220347170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => Method of Reducing Brow Ache
[patent_app_type] => utility
[patent_app_number] => 17/730376
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17730376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/730376 | Method of Reducing Brow Ache | Apr 26, 2022 | Abandoned |
Array
(
[id] => 19816687
[patent_doc_number] => 20250074894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-06
[patent_title] => NITROPHENYL-ACRYLAMIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/555505
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555505
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555505 | NITROPHENYL-ACRYLAMIDES AND USES THEREOF | Apr 14, 2022 | Pending |
Array
(
[id] => 19263567
[patent_doc_number] => 20240207264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF THE ANDROGEN RECEPTOR AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/555599
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -74
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555599
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555599 | PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF THE ANDROGEN RECEPTOR AND USES THEREOF | Apr 14, 2022 | Pending |
Array
(
[id] => 19265226
[patent_doc_number] => 20240208925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => ISOQUINOLINE DERIVATIVES FOR USE AS ANTIVIRAL AND ANTITUMOUR AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/287011
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287011
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287011 | Isoquinoline derivatives for use as antiviral and antitumour agents | Apr 13, 2022 | Issued |
Array
(
[id] => 18225363
[patent_doc_number] => 20230064357
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHOD FOR TREATMENT OF PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/720777
[patent_app_country] => US
[patent_app_date] => 2022-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17720777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/720777 | METHOD FOR TREATMENT OF PARKINSON'S DISEASE | Apr 13, 2022 | Abandoned |
Array
(
[id] => 17944311
[patent_doc_number] => 20220331328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => 1-METHYLXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/715911
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715911 | 1-methylxanthine-based bioactive composition and method of use thereof | Apr 6, 2022 | Issued |
Array
(
[id] => 17759217
[patent_doc_number] => 20220232829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => DUAL ACTIVE INSECTICIDAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/715133
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715133 | Dual active insecticidal compositions | Apr 6, 2022 | Issued |
Array
(
[id] => 19586358
[patent_doc_number] => 20240383915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => OXAZEPINE COMPOUNDS AND USES THEREOF IN THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/554438
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 131749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554438
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554438 | OXAZEPINE COMPOUNDS AND USES THEREOF IN THE TREATMENT OF CANCER | Apr 5, 2022 | Pending |
Array
(
[id] => 19232092
[patent_doc_number] => 20240189283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => L-ERGOTHIONEINE-CONTAINING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/555223
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7628
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555223
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555223 | L-ERGOTHIONEINE-CONTAINING COMPOSITION | Mar 29, 2022 | Pending |
Array
(
[id] => 19233693
[patent_doc_number] => 20240190885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/552482
[patent_app_country] => US
[patent_app_date] => 2022-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -91
[patent_words_short_claim] => 551
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552482
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552482 | KRAS PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | Mar 29, 2022 | Pending |
Array
(
[id] => 20687664
[patent_doc_number] => 12617799
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-05
[patent_title] => Pyrazolopyrimidinone compounds
[patent_app_type] => utility
[patent_app_number] => 18/552297
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25598
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 383
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552297
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552297 | Pyrazolopyrimidinone compounds | Mar 24, 2022 | Issued |
Array
(
[id] => 20328392
[patent_doc_number] => 12458649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Contraceptive compositions with reduced adverse effects
[patent_app_type] => utility
[patent_app_number] => 17/701588
[patent_app_country] => US
[patent_app_date] => 2022-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 20050
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17701588
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/701588 | Contraceptive compositions with reduced adverse effects | Mar 21, 2022 | Issued |
Array
(
[id] => 17702933
[patent_doc_number] => 20220202939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PREPARATION FOR IMPROVING ACTIVITY AND/OR THERMAL STABILITY OF SUPEROXIDE DISMUTASE, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/699204
[patent_app_country] => US
[patent_app_date] => 2022-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17699204
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/699204 | PREPARATION FOR IMPROVING ACTIVITY AND/OR THERMAL STABILITY OF SUPEROXIDE DISMUTASE, AND APPLICATION THEREOF | Mar 20, 2022 | Abandoned |
Array
(
[id] => 17718997
[patent_doc_number] => 20220211716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => ANTIVIRAL PRODRUGS AND NANOFORMULATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/655483
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17655483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/655483 | Antiviral prodrugs and nanoformulations thereof | Mar 17, 2022 | Issued |
Array
(
[id] => 19462320
[patent_doc_number] => 20240315989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => METHODS OF TREATING COVID-19
[patent_app_type] => utility
[patent_app_number] => 17/698361
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78600
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698361 | METHODS OF TREATING COVID-19 | Mar 17, 2022 | Abandoned |
Array
(
[id] => 17685748
[patent_doc_number] => 20220193040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Use of Isoxazoline Derivatives for the Treatment or Prevention of Arthropod Infestations in Poultry
[patent_app_type] => utility
[patent_app_number] => 17/653950
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653950
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653950 | Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry | Mar 7, 2022 | Issued |
Array
(
[id] => 19170826
[patent_doc_number] => 20240156800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => EP300 DEGRADER AND USES THEREOF IN NEUROBLASTOMA
[patent_app_type] => utility
[patent_app_number] => 18/280877
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280877
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280877 | EP300 DEGRADER AND USES THEREOF IN NEUROBLASTOMA | Mar 7, 2022 | Pending |